The First Case Series of Cryopyrin-Associated Periodic Syndrome in Korea

被引:7
|
作者
Han, Jong Hee [1 ]
Je, Yeon Jin [1 ]
Yoon, Hyun Je [1 ]
Ahn, Jong Gyun [2 ]
Lee, Jin-Sung [3 ]
Park, Jung-Won [4 ]
Park, Hye Jung [1 ]
机构
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, 211 Eonju Ro, Seoul 06273, South Korea
[2] Yonsei Univ, Coll Med, Severance Childrens Hosp, Dept Pediat, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Pediat, Div Clin Genet, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Internal Med, Div Allergy & Immunol, Seoul, South Korea
关键词
Cryopyrin-associated periodic syndromes; NLRP3; protein; human; NLR family; pyrin domain-containing 3 protein; urticaria; arthralgia; COLD AUTOINFLAMMATORY SYNDROME; URTICARIA; MUTATION; DISEASE;
D O I
10.4168/aair.2019.11.4.583
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Cryopyrin-associated periodic syndrome (CAPS) is a hereditary autoinflammatory syndrome caused by mutations in NLRP3 (encoding cryopyrin), which presents with fever, fatigue and arthralgia. Thus far, however there have been no reports of CAPS in Korea. Herein, we report 3 cases of CAPS for the first time in Korea. The first case, a 28-year-old man with recurrent urticaria, arthralgia and fever induced by cold, all of which were observed in his father, showed elevated erythrocyte sedimentation rate and C-reactive protein. He exhibited a p.Gly303Asp variant of the NLPR3 gene. The second case, a 2-year-old girl who had recurrent urticaria, arthritis and oral and genital ulcers, was positive for HLA B51 and a p.Glu569Lys mutation in exon 3 of the NLRP3 gene. Administration of anakinra greatly improved her symptoms. The third case, a 4-year-old boy who presented with recurrent urticaria, arthralgia, and fever, exhibited a p.Val72Met mutation in exon 1 of the NLRP3 gene. Administration of tocilizumab improved all of his symptoms. This small case series suggests that clinicians consider CAPS and conduct genetic studies when arthralgia and fever are accompanied by urticaria in Korea.
引用
收藏
页码:583 / 588
页数:6
相关论文
共 50 条
  • [31] Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response
    Justin R. Yu
    Kieron S. Leslie
    Current Allergy and Asthma Reports, 2011, 11 : 12 - 20
  • [32] Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response
    Yu, Justin R.
    Leslie, Kieron S.
    CURRENT ALLERGY AND ASTHMA REPORTS, 2011, 11 (01) : 12 - 20
  • [33] Misstatements on cryopyrin-associated periodic fevers
    Wanderer, Alan
    Hoffman, Hal
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 101 (01) : 111 - 112
  • [34] Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
    Kone-Paut, Isabelle
    Galeotti, Caroline
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (10) : 1083 - 1092
  • [35] Ventricular fibrillation in a young woman with cryopyrin-associated periodic syndrome
    Endo, K.
    Suzuki, A.
    Suzuki, T.
    Shiga, T.
    Sato, K.
    Shoda, M.
    Hagiwara, N.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1215 - 1215
  • [36] Canakinumab for the cryopyrin-associated periodic syndromes
    Sinisa Savic
    Michael F. McDermott
    Nature Reviews Rheumatology, 2009, 5 : 529 - 530
  • [37] Canakinumab for the cryopyrin-associated periodic syndromes
    Savic, Sinisa
    McDermott, Michael F.
    NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 529 - 530
  • [38] Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS)
    Mamoudjy, Nafissa
    Maurey, Helene
    Marie, Isabelle
    Kone-Paut, Isabelle
    Deiva, Kumaran
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [39] Cryopyrin-associated periodic syndrome: a treatable genetic inflammatory condition
    Christensen, Maja
    Wallis, Mathew
    Jessup, Peter
    Lemelle, Irene
    Jones, Dean L.
    PRACTICAL NEUROLOGY, 2021, 21 (05) : 424 - 426
  • [40] Cryopyrin-associated Periodic Syndromes and the Eye
    Oberg, Thomas J.
    Vitale, Albert T.
    Hoffman, Robert O.
    Bohnsack, John F.
    Warner, Judith E.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2013, 21 (04) : 306 - 309